• 한국약용작물학회지
• /
• 제4권1호
• /
• pp.78-85
• /
• 1996

강활(羌活)(Angelic koreana Max.)의 캘러스 배양(培養)과 식물체(植物體) 재분화(再分化)에 필요한 배양(培養) 조건(條件)을 구명(究明)하기 위하여 유엽(幼葉) 및 미숙화(未熟花)의 화경(花梗) 배양(培養)에 미치는 생장조절제(生長調節劑), sucrose 및 배지(培地) 응고제(凝固劑) 등의 영향(影響)을 조사(調査)한 결과(結果)는 다음과 같다. 1. 유엽(幼葉) 유래(由來) 캘러스 생장은 1 mg/l 2,4-D를 첨가한 MS배지에서 왕성하여, 생체중(生體重) 및 건물중(乾物重)이 가장 높았다. 2. 캘러스 생장을 위한 적정 sucrose농도는 2% 였으며, sucrose 농도가 증가함에 따라 캘러스 생장이 억제되는 경향이었다. 3. 배지(培地) 응고제(凝固劑)에 따른 캘러스 생장은 1.2% agar, 0.4% Gelrite에서 생체중(生體重) 및 건물중(乾物重)이 가장 높았다. 4. 배지내 10mg/l ABA와 $5{\sim}10mg/l\;AgNO_3$ 첨가는 유엽(幼葉) 유래(由來) 캘러스의 갈변화(褐變化)를 현저히 억제하였으며, 무처리(無處理)보다 캘러스 활력도 높았다. 5. 미숙(未熟) 화(花)의 화경(花梗) 배양(培養)에서 캘러스 형성율은 NAA보다 2,4-D가 효과적이었으며, 2mg/l 2,4-D를 첨가한 배지에서 81.7%로 가장 높았고, 캘러스 생장도 왕성하였다. 6. 유엽(幼葉) 유래(由來) 캘러스로부터는 식물체(植物體)가 재분화(再分化)되지 않았으나, 미숙(未熟) 화(花)의 화경(花梗) 유래(由來) 캘러스는 0.5 mg/l 2,4-D, 1 mg/l kinetin, 5 mg/l ABA와 5 mg/l $AgNO_3$ 첨가배지에서 체세포(體細胞) 배(胚)가 형성되었으며, 이들 체세포(體細胞) 배(胚)로부터 식물체(植物體)가 발생(發生)되었다. 무처리(無處理) 229.1kg보다 63.3kg 더 무거운 28%의 증수(增收) 효과(效果)를 나타냈으며 60배(倍), 80배(倍), 처리시(處理時)에도 각각(各各) 6%, 3% 증수(增收)되었다.로 42% 소득(所得)이 증대(增大)되었다.7. 3%였고 개분함량(漑粉含量)은 10월(月), 11월(月) 각각 30. 8%, 27, 7%로서 수확시기별(收穫時期別) 함량(含量)에는 변이폭(變移幅)이 크지 않았다. 이를 종합하면 유효성분(有效成分)의 함량(含量)이 높은 11월(月) 30일(日) 수확(收穫)이 10월(月) 30일(日) 수확(收穫)보다 유리(有利)할 것으로 판단된다. 4. 구경(球莖) 크기별 약효성분(藥效成分)의 함량변이도 커서 10월(月), 30일(日) 경우 S가 0. 53%로 가장 높고 M, L 순(順)으로 구경(球莖)이 커지면서 함량(含量)이 감소(感少)하였다. 5. 정식(定植)깊이 $0{\sim}1cm$가 다른 정식(定植)깊이에 비교하여 수량(收量)이 206kg/10a로 가장 많았으며 유효성분(有效成分) 변이(變移)는 $0. 33{\sim}0. 39%$로서 정식(定植)깊이에 따라 크지않은 것을 고려하면 택사(澤瀉) 재배시(栽培時) 정식(定植)깊이는 $0{\sim}1cm$가 가장 유리(有利)할 것으로 판단된다.군에서 18.8% 갑상선기능항진증 환자군에서 16.6%으로 나타났으며 이러한 slow acetylator의 빈도는 통계적으로 유의하지 않았다(chi-square, p= 0.83 표 3.). 결 론: Metoprolol을 표지 약물로 측정한 CYP2D6 poor metabolizer는 정상인과 갑상선기능항진증 환자군 모두에서 관찰할 수 없었다. N-acetyltransferase의 활성도는 갑상선기능항진증 환자군과 정상 대조군 사이에 유의한 차이를 보이지

• 분석과학
• /
• 제12권6호
• /
• pp.534-539
• /
• 1999

Penicillium, Aspergillus 및 Fusarium에 오염된 밀(Triticum aestivum L.), 콩(Glycine max Merr), 옥수수(Zea mays L.)에서 HPLC를 이용하여 주요 독소들을 검정하였다. Penicillium 독소인 brefeldin A는 밀에서 3.1~270 ppm, 콩에서 45~230 ppm, 옥수수에서 1030~1240 ppm 다량 검출되었다. Citreoviridin과 griseofulvin은 밀, 콩, 옥수수에서 각각 40~80 ppm과 3.6~26.0 ppm이 검출되었다. 그리고 citrinin과 patulin은 밀, 콩, 옥수수에서 각각 0.3~4.0 ppm과 420~3800 ppm로 검출되었고, 특히 옥수수에서 다량 검출되었다. Aspergillus 독소로 ochratoxin A는 밀에서 730 ppm, 콩에서 12.4 ppm, 옥수수는 310 ppm이 검출되었다.

• 대한화학회지
• /
• 제40권1호
• /
• pp.72-80
• /
• 1996

Chitinase를 생성하는 세균인 serratia marcescens JM을 해안 갯벌 시료로부터 분리하여, ammonium sulfate precipitation, affinity adsorption, hydroxylapatite와 Sephadex G-200 column chromatography를 통하여 정제하였다. 정제된 chitinase는 7.1% 회수율과 4.22의 정제도를 나타내었으며, 전기영동시 단일밴드를 얻을 수 있었고, SDS-PAGE에 의해 측정된 분량은 59,000으로 나타났다. 정제된 chitinase의 $K_m$과 $V_{max}$는 5.71mg/mL과 39.8 unit/mL로 나타났다. Chitinase의 최적활성 pH와 온도는 7과 50$^{\circ}C$였고 최적안정pH는 7.0이며 50$^{\circ}C$이하에서는 안정하였다. $Cu^{2+}\;Ca^{2+}$ 및 $Mg^{2+}$는 효소활성을 증가시켰으나 $Hg^{2+}$와 $I_2$는 효소 활성을 억제시켰다. 또한 cysteine은 효소활성을 증가시키나 EDTA, MIA, PCMB, 및 SDS는 효소활성을 억제시켰다. 해수 음이온 중 $MG^{2+},\;Ca^{2+},\;K^+$는 효소활성을 약간 증가시켰으나 $Na^{2+}$ 이온은 1mM이상농도에서 활성이 억제되었다. 본 논문에서 정제된 chitinase는 여러가지 특이점이 있는 serratia효소였다.

• 한국미생물·생명공학회지
• /
• 제17권3호
• /
• pp.173-177
• /
• 1989

HeLa 세포주의 연속 배양시 세포수가 배지의 이동속도가 증가함에 따라 감소하는 현상을 나타냈으며, 최대 세포수를 유지할 때의 dilution rate은 0.012(1/h)로 wash-out인 0.050(1/h)보다 극히 낮으며, dilution rate이 0.030(1/h)일 때 2.0(mL of cells/L/h)의 최대 세포 생산속도를 보였다. 또한 낮은 배지 이동속도에서 세포수의 감소에 따른 maintenance term의 존재를 확인했다. 더불어 packed cell volume파 산소소비속도의 측정값이 실제 세포증식과 밀접한 관계가 있음이 입증되어 간접방법에 의한 생육도치 측정이 가능하게 되었다. 또한 산소 yield model에 의해 최대 산소 수율, $Y_{O2}^{max}$과 maintenance 산소소비속도, m$_{O2}$가 각각 4.1$\times$$10^5$(cells/mmole $O_2$)와 10.71$\times$$10^{-9}$(mmole $O_2$/ cells/h)로 측정되었다.

• 한국식품영양학회지
• /
• 제33권2호
• /
• pp.167-173
• /
• 2020

To increase the functional material content of soybean, a repetitive steaming and drying process was used. We investigated the changes in the total polyphenol content, the antioxidant activity, and the angiotensin-I converting enzyme (ACE) inhibition in soybean following nine rounds of steaming and drying. Soybean was steamed 9 times for 2 h and then dried 9 times from 55℃ to 73℃ for 3 h. The total polyphenol content in the soybean reached a maximum value of 60.47 mg GAE eq./100 g at 73℃ while the total polyphenol content in the raw soybean reached 25.17 mg GAE eq./100 g. In the raw soybean samples, the DPPH radical scavenging activity (5 mg/mL) was 8.04% but it increased by 43.29% after drying 9 times to 73℃. ABTS radical scavenging activity also improved following 9 rounds of steaming and drying. ACE inhibitory activity of the soybean dried 9 times at 73℃ was 58.94% at 10 mg/mL. These results showed that steaming and drying soybean 9 times enhanced the antioxidant activity and the ACE inhibitory activity of soybean. Therefore, more research on the biological and anti-hypertensive activity of soybean using this steaming and drying method is necessary.

• 한국환경보건학회지
• /
• 제40권5호
• /
• pp.407-412
• /
• 2014

Objectives: The internal dose of ethyl parabens is important in order to evaluate the risk of this chemical. However, there are little PK model data for parabens to apply this. This experiment attempted PK modeling to ascertain PK values. Methods: Twenty mg/kg ethyl paraben was administered orally to Sprague-Dawley rats at the same point in time. The rats were sacrificed at times 0, 15, 30 and minutes, and 1, 2, 4, 8, 12, 24 hours after oral gavage. Blood and urine were collected and pretreated for analysis. Accuracy, precision and LOD (limit of detection) were calculated for this analysis. Ethyl paraben, detected by HPLC-MS, was applied to PK modeling using Berkeley Madonna. Results: This study showed 100.1-103.7% accuracy, 1.4-3.7% precision and a 1.0 ng/mL limit of detection. Orally administered ethyl paraben reached maximum concentration after 30 minutes of dosing in serum and urine of rats. The concentrations were 2,354 ng/mL in serum and 386,000 ng/mL in urine samples. These peak concentrations were excreted after one hour of intubation over 12 hours. For the pharmacokinetic parameters of ethyl paraben revealed using Berkeley Madonna, the absorption rate was 5.539/hour, the excretion rate was 0.048/hour, the half-life was 14.441 hours and AUC was 481,186 ng hour/mL. Conclusion: Orally administered ethyl paraben was absorbed rapidly in rats and excreted in urine. This chemical, ethyl paraben, accumulated in the body but was excreted over 12 hours after dosing.

• Archives of Pharmacal Research
• /
• 제28권4호
• /
• pp.469-475
• /
• 2005

The purpose of this study was to investigate the effect of a cotreatment of bamboo concentrates (Jukcho solution; 0.75, 1.5, and 3.0 mL/kg) with the chemotherapeutic agent paclitaxel on the bioavailability of orally administered paclitaxel (50 mg/kg) in rats. The effect of a pretreatment of bamboo concentrates (1.5 and 3.0 mL/kg for 1.0 h or a consecutive 3 day) was also examined. The paclitaxel plasma concentrations of rats orally administered paclitaxel plus bamboo concentrates (coadministration, 3.0 mL/kg and pretreatment, 1.5 and 3.0 mL/kg) were significantly higher than those of rats treated with paclitaxel alone. Plasma concentrations of paclitaxel in groups pretreated with bamboo concentrates for 3 day were markedly higher than those of a paclitaxel control group at the measured time points. The areas under plasma concentration-time curves (AUCs) of paclitaxel in groups pretreated with bamboo concentrates were elevated and the absolute bioavailability ($AB\%$) and relative bioavailability ($RB\%$) of paclitaxel were also significantly higher than those in the control group. The peak concentration ($C_{max}$), half-life ($t_{1/2}$), and the elimination rate constant ($K_{el}$) of paclitaxel after 3 day of pretreatment with bamboo concentrates were also significantly higher than those in the control, but the time required to reach the maximum plasma concentration ($T_{max}$) of paclitaxel was unaffected by the bamooo concentrates. Western blot analyses demonstrated that the level of CYP3A4 was increased in the livers of rats treated orally with paclitaxel, but this was reversed by pretreating with bamboo concentrates. These results show that bamboo concentrates enhance the bioavailability of orally administered paclitaxel and this effect may be associated with a diminished expression of CYP3A4 in the liver.

• Archives of Pharmacal Research
• /
• 제29권6호
• /
• pp.514-519
• /
• 2006

A simple HPLC method using UV detection was developed and validated for the determination of levodropropizine (LDP) In dog plasma. The sample was prepared for injection using a liquid-liquid extraction method with 1-phenypiperazine as the internal standard. The mobile phase was methanol - diethylamine solution (0.05 M) (20:80, v/v, pH adjusted to 3.0 with $H_3PO_4$) with a detection wavelength of 240 nm. The limit of quantitation (LOQ) of LDP in a biological matrix was determined to be 25.25 ng/mL. The calibration curve was linear across the concentration range of 25.25 to 2020 ng/mL. The intra-day and inter-day precision values (CV%) were within 7% and accuracy (R.E. %) was within 6% of the nominal values for medium (252.5 ng/mL) and high (2020 ng/mL) LDP concentrations. For the LDP concentration at the LOQ, the intra-day and inter-day precision and accuracy were within 20% and 10%, respectively. The average absolute recovery for LDP was 70.28%. This method was successfully used to analyze plasma samples in a steady-state bioavailability study of a newly developed sustained-release LDP tablets (SR) using immediate-release tablets (IR) as the reference. The relative bioavailability of the SR was determined to be $106.3\;{\pm}\;12.8%$ (n=6). The $C_{max}$ of the SR was significantly lower (p<0.05), and the $t_{max}$ was significantly longer than that of the IR (p<0.05). The results of ANOVA and two one-sided tests indicated that the SR exhibited acceptable sustained release properties and was bioequivalent to the IR.

• Archives of Pharmacal Research
• /
• 제27권7호
• /
• pp.806-810
• /
• 2004

Metformin is a biguanide antihyperglycemic agent often used for the treatment of non-insulin dependent diabetics (NIDDM). In this study, the pharmacokinetics and pharmacodynamics of metformin were investigated in Korean healthy volunteers during a fasting state for over 10 h. In order to evaluate the amount of glucose-lowering effect of metformin, the plasma concentrations of glucose were measured for a period of 10 h followed by the administration of metformin (oral 500 mg) or placebo. In addition, the concentration of metformin in blood samples was determined by HPLC assay for the drug. All volunteers were consumed with 12 g of white sugar 10 minutes after drug intake to maintain initial plasma glucose concentration. The time courses of the plasma concentration of metformin and the glucose-lowering effect were analyzed by nonlinear regression analysis. The estimated $C_{max}$, $T_{max}$, $CL_{t}$/F (apparent clearance), V/F(apparent volume of distribution), and half-life of metformin were 1.42$\{pm}$0.07 $\mu\textrm{g}$/mL, 2.59$\{pm}$0.18h, 66.12$\{pm}$4.6 L/h, 26.63 L, and 1.54 h respectively. Since a significant counterclock-wise hysteresis was found for the metformin concentration in the plasma-effect relationship, indirect response model was used to evaluate pharmacodynamic parameters for metformin. The mean concentration at half-maximum inhibition $IC_{50}$, $k_{in}$, $k_{out}$ were 2.26 $\mu\textrm{g}$/mL, 83.26 $H^{-1}$, and 0.68 $H^{-1}$, respectively. Therefore, the pharmacokinetic-pharmacodynamic model may be useful in the description for the relationship between plasma concentration of metformin and its glucose-lowering effect.

• Journal of Veterinary Science
• /
• 제21권5호
• /
• pp.60.1-60.11
• /
• 2020

Background: Tumor-associated neoangiogenesis is a crucial target for antitumor therapies. Thalidomide (TAL) is a promising anti-neoangiogenetic drug that has recently been used in the treatment of several malignancies in dogs. Objectives: The aim of the study was to assess the pharmacokinetics of TAL after single oral administration in dogs. Additionally, the influence of feeding on the pharmacokinetic profile of TAL in dogs has been preliminarily investigated. Methods: Six healthy adult female Labradors were enrolled according to a randomized single-dose, 2-treatment, 2-phase, paired 2 × 2 cross-over study design. The dogs were administered a single 400 mg capsule of TAL in fasted and fed conditions. Blood was collected from 15 min to 48 h after dosing, and TAL quantified in plasma by a validated high-performance liquid chromatography method. The pharmacokinetics of TAL were analyzed using a non-compartmental approach. Results: TAL concentration was quantifiable up to 10 h and 24 h after fasted and fed conditions, respectively. C_max (fasted, 1.34 ± 0.12 ㎍/mL; fed, 2.47 ± 0.19 ㎍/mL) and T_max (fasted, 3 h; fed, 10 h) differed substantially between the 2 groups. AUC and t_1/2λz were significantly higher in fed (42.46 ± 6.64 mg × h/L; 17.14 ± 4.68 h) compared to fasted (12.38 ± 1.13 mg × h/L; 6.55 ± 1.25 h) dogs. The relative oral bioavailability of TAL for the fasted group was low (36.92% ± 3.28%). Conclusions: Feeding affects the pharmacokinetics of oral TAL in dogs, showing a delayed, but higher absorption with different rate of elimination. These findings are of importance in clinical veterinary settings, and represent a starting point for further related studies.